Federal regulators are investigating the deaths of two patients who received injections of a longer-lasting version of Eli Lilly's antipsychotic Zyprexa. The Food and Drug Administration said Tuesday that the patients died three to four days after receiving an appropriate dose of the drug known...
Mississippi's attorney general says he still considers Google's responses to allegations that it...
If doctors and patients used prescription drugs more wisely, they could save the U.S. health...
The American Medical Association is recognizing obesity as a disease. Dr. Lou Aronne, an obesity specialist at New York Presbyterian Hospital, talks about the significance of this change and what it means for health care costs, awareness and prevention.
Americans spend $34 billion a year on vitamins, supplements and alternative therapies. Now, a new book debunks treatments that may not really work. Dr. Paul Offit of the Children's Hospital of Philadelphia discusses his book, "Do You Believe in Magic?"
Shares of Protalix BioTherapeutics jumped in premarket trading Wednesday after the company announced a deal that requires the Brazilian government to buy at least $280M of the company's Gaucher disease treatment. The Israeli company said an arm of the Brazilian Ministry of Health has committed to buying at least $40M of the drug annually during the seven-year agreement for Uplyso.
TruAir’s broad-spectrum protection — NIOSH approved N95, N99, and P100 level protection — have made the entire TruAir line extremely popular in myriad industries. TruAir and TruAir Plus, NIOSH approved N95 and N99-level protection respectively, feature a similar design with a large, molded shell to aid in the reduction of breathing resistance.
The "smart" blister package, Ecoslide-RX® with integrated Med-ic® technology is senior friendly and child-resistant. Ideal for clinical trials where dosing data should be precisely recorded, Ecoslide-RX with Med-ic incorporates an electronic module and printed sensor grid inside the package, both of which are invisible to the patient.
The PPS SuperCount is a tablet counter operating at speeds up to 160 bottles per minute (24 track counter), and the new design features maximize efficiency while minimizing downtime. The vibrator trays have been redesigned to make them lighter which results in better response to vibration and faster, smoother product movement into the count eyes for a more precise product feed.
Over 80 ribbon blenders, sized for different working volumes and bulk densities, are now available. Built-to-order custom units are also offered with fast lead times like the pictured 10-cu.ft. sanitary ribbon blender featuring 150-grit stainless steel 316 internal and external surfaces, bottom discharge extruder, lantern rings, spray bar system with atomizing nozzles, load cells and a NEMA 4X Ross SysCon control panel.
The nXDS-C features the Chemraz® exhaust valve which is used for applications involving pumping organic solvents or other materials that may attack the standard pumps’ fluroelastomer exhaust valve, causing it to deteriorate rapidly.
AMRI announced today that its Burlington, Mass., site has received approval to expand its current U.S. Drug Enforcement Administration (DEA) registration to handle Schedule 2 and 2N controlled substances. The license represents the DEA’s acknowledgement of Burlington’s physical security and quality systems, including inventory control and documentation.
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer. Royalty offered earlier this month to pay $13 per share for each Elan share plus up to $2.50 per share in payments based on performance milestones. That totaled about $7.76 billion not counting the milestone payments.
AstraZeneca today announced that its new UK-based global research and development centre and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a highly-skilled workforce of approximately 2,000.
Mary Mahoney, North Shore Long Island Jewish Medical director of Emergency Planning and Preparedness, discusses the steps her hospital system is taking to prepare for a possible pandemic. In light of recent outbreaks around the globe pandemic preparation is becoming more important than ever.
Royalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel's decision requiring it to lapse its offer for Elan Corporation, plc if, among other things, Elan shareholders approved the Share Repurchase Program.
There's good news for most companies that provide health benefits for their employees: America's slowdown in medical costs may be turning into a trend, rather than a mere pause. A report Tuesday from accounting and consulting giant PwC projects lower overall growth in medical costs for next year, even as the economy gains strength and millions of uninsured people receive coverage under President Barack Obama's health care law.
Canadian drugmaker Valeant Pharmaceuticals International Inc. said Monday it will sell $1.75 billion in stock to help fund its acquisition of Bausch + Lomb. Valeant did not say how many shares it plans to sell. The company said it plans to raise $1.75 billion before discounts, expenses, and other...